long term effects of glp 1 agonists The expanding role GLP-1 receptor agonists: a narrative review of current evidence and future directions GI Adverse Effects of Glucagon-Like
Description
The challenge: supplement contamination remains a persistent problem
Glucagon-like peptide-1 receptor agonists and prevention of stroke
Recently, a surfactant conjugated co-agonist peptide 17 was shown to have a half-life of 52 hours in vivo and at a higher dose led to 40% body weight loss in obese rats over 27 days (79)
This drives higher insulin output and worsens abdominal fat accumulation
10.1016/j.cmet.2017.04.013 27 GreinerT
Finally, each section includes separate presentations of the results from the meta-analyses
